Savacor Inc. Acquired by St. Jude Medical in December 2005

Savacor, Inc.: Savacor® is a medical device company founded to develop, manufacture, market and sell a new concept in implantable medical devices aimed at the rapidly growing segment of cardiac patients with congestive heart failure. Savacor has heart failure diagnostic and therapy guidance products and technologies under development and in clinical evaluation.

The company currently has a small implantable sensor device in clinical trials both in the United States and internationally that measures left atrial pressure and body temperature to help physicians detect and manage symptoms associated with progressive heart failure.

Increased pressure in the left atrium is a predictor of pulmonary congestion, which is the leading cause of hospitalization for congestive heart failure patients. "The Savacor technology has exciting potential and will complement the development efforts already underway at St. Jude Medical in managing the co-morbidities of heart failure patients," said Michael J. Coyle, President of St. Jude Medical's Cardiac Rhythm Management business. "We are pleased to welcome the Savacor team to St. Jude Medical."Under terms of the agreement, St. Jude Medical will acquire Savacor, Inc. for $50 million.